Cumberland Pharmaceuticals Inc.CPIXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -160.00% |
| Q2 2025 | -162.50% |
| Q1 2025 | 157.14% |
| Q4 2024 | -27.27% |
| Q3 2024 | -37.50% |
| Q2 2024 | 42.86% |
| Q1 2024 | 68.18% |
| Q4 2023 | -528.57% |
| Q3 2023 | -216.67% |
| Q2 2023 | 500.00% |
| Q1 2023 | 105.88% |
| Q4 2022 | -466.67% |
| Q3 2022 | 66.67% |
| Q2 2022 | 0.00% |
| Q1 2022 | 65.38% |
| Q4 2021 | -271.43% |
| Q3 2021 | -187.50% |
| Q2 2021 | 700.00% |
| Q1 2021 | 116.67% |
| Q4 2020 | -88.68% |
| Q3 2020 | 47.87% |
| Q2 2020 | 12.86% |
| Q1 2020 | -16.67% |
| Q4 2019 | 53.85% |
| Q3 2019 | -267.23% |
| Q2 2019 | -637.50% |
| Q1 2019 | 96.57% |
| Q4 2018 | -27.27% |
| Q3 2018 | -139.13% |
| Q2 2018 | 69.33% |
| Q1 2018 | -194.70% |
| Q4 2017 | -8.76% |
| Q3 2017 | 85.38% |
| Q2 2017 | -300.00% |
| Q1 2017 | -72.41% |
| Q4 2016 | -564.00% |
| Q3 2016 | 433.33% |
| Q2 2016 | 80.65% |
| Q1 2016 | -255.00% |
| Q4 2015 | 0.00% |